This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Jan;95(1):201.

doi: 10.1016/j.gie.2021.09.034.

Response

Andrea Lisotti¹, Antonio Facciorusso², Nicole Brighi³, Pietro Fusaroli¹

Affiliations

Affiliations

¹ Gastroenterology Unit, Hospital of Imola, University of Bologna, Bologna, Italy.
² Section of Gastroenterology, Department of Surgical and Medical Sciences, University of Foggia, Foggia, Italy.
³ Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy.

PMID: 34895619
DOI: 10.1016/j.gie.2021.09.034

Comment

Response

Andrea Lisotti et al. Gastrointest Endosc. 2022 Jan.

. 2022 Jan;95(1):201.

doi: 10.1016/j.gie.2021.09.034.

Authors

Andrea Lisotti¹, Antonio Facciorusso², Nicole Brighi³, Pietro Fusaroli¹

Affiliations

¹ Gastroenterology Unit, Hospital of Imola, University of Bologna, Bologna, Italy.
² Section of Gastroenterology, Department of Surgical and Medical Sciences, University of Foggia, Foggia, Italy.
³ Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy.

PMID: 34895619
DOI: 10.1016/j.gie.2021.09.034

No abstract available

PubMed Disclaimer

Comment on

Contrast-enhanced EUS in differentiating malignant pancreatic cystic neoplasms: evidence should be based on clinical settings.
Zhang ZF. Zhang ZF. Gastrointest Endosc. 2022 Jan;95(1):200-201. doi: 10.1016/j.gie.2021.08.020. Gastrointest Endosc. 2022. PMID: 34895617 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science